Explore the Agenda

7:00 am Check In, Coffee & Light Breakfast

7:55 am Chair’s Opening Remarks

Environmental Health & Safety Lead, New England BioLabs

Integrating AI into the Future of EHS Leadership, Culture, & Operations

8:00 am Predict, Prevent, Protect: Responsible AI for Risk & Lab Safety

Global Senior Director, Environmental Health Safety & Risk Programs, Amgen
  • Using predictive analytics to identify incident precursors, SIF trends, and emerging hazards to turn lagging metrics into leading insight
  • Comparing global standards to local SOPs with AI to detect documentation gaps and enhance audit readiness
  • Exploring AI ergonomics/PIV monitoring use cases while setting privacy, HR, and “no-punitive surveillance” guardrails

8:30 am Session Reserved for SciSure

8:40 am Case Study: Explore Digitalization, Standardization, Simplification & Modernization of EHS Management and Culture

Global Director & Lead, Environment, Health, & Safety, Zoetis
  • EHS Observation Reporting- Good Catch Program
  • Proactive Leadership Involvement- FOCUS Walks
  • Leading and Lagging Indicators in Practice

9:10 am Roundtable Discussion: Lean Teams, Smart Tools: Practical AI Uplift for EHS Operations

  • Capturing and structuring legacy expertise through AI-powered knowledge libraries to retain institutional memory amid workforce change
  • Personalizing training, procedures, and communication through adaptive AI tools that connect relevance (“why it matters to me”) to safety behaviour
  • Leveraging AI for prioritization, workload optimisation, and decision support, while maintaining interpretive oversight, human accountability, and global-local flexibility

10:00 am Speed Networking

A prime chance to make the most of in-person networking and forge new connections as new companies enter and existing ones broaden their presence within the EHS for biopharma space. This is designed to maximize your exposure to a wide range of new individuals and serve as a catalyst for ongoing discussions throughout the summit.

10:30 am Morning Break & Refreshments

Tackling the Lack of Qualified EHS Professionals & Implementing Mindset Based Training for Enhanced Uptake & Continued Engagement

11:00 am Beyond the Checkbox: Re-energising EHS Training for Real Engagement & Lasting Impact

Site Health, Safety, Environmental Lead, Sanofi
  • Explore how traditional compliance-driven, click-through training models have become disengaging and ineffective, and how biopharma leaders are re-designing learning through mixed-modal approaches including in-person sessions, AI-enhanced voice content, and interactive sustainability modules such as My Green Lab
  • Demonstrate how dynamic, measurable training can build true behavioural change, improve knowledge retention, and integrate non-regulatory opportunities like sustainability into everyday lab culture
  • Discuss practical frameworks to balance digital efficiency with human connection, ensuring EHS training is not only compliant but also inspiring, data-driven, and capable of transforming workplace culture

11:30 am Session Reserved for Triumvirate Environmental

11:40 am Roundtable Discussion: Embedding Behaviour-Based Safety in Biopharma Culture

Associate Director - Environmental Health & Safety, MannKind Corporation
Principal, Environmental, Health and Safety Specialist, Alkermes
  • Explore how to translate EHS training into consistent, observable safety behaviours that reduce human error and strengthen trust across teams
  • Share practical techniques for constructive communication, peer coaching, and intervening on unsafe acts without confrontation or blame
  • Discuss how to measure and sustain behavioural engagement over time, ensuring safety habits persist across shifting teams and evolving operations

12:30 pm Lunch & Networking Break

Human-Centred Safety: Integrating Ergonomics & Mental Health into the Core of Biopharma EHS

1:30 pm Bridging the Gap Between Front-Line Safety & Executive Priorities to Create a Culture of Shared Accountability & Lasting Engagement

Director, EHS-Manufacturing, Ultragenyx
  • Highlighting the gap between operational safety efforts and executive priorities driven by production, deadlines, and shareholder value
  • Exploring tiered management systems and cross-functional safety committees that foster accountability at every level as a strategy to win leadership engagement by aligning EHS outcomes with business performance, modelling visible commitment, and embedding safety goals into leadership routines and communications
  • Transforming leadership support from passive endorsement to active sponsorship by creating a cascading culture where safety, wellbeing, and performance reinforce each other across the organization

2:00 pm Mitigating the Impact of Musculoskeletal Disorders (MSDs)

Vice President - Clinical Development, The Jackson Laboratory
  • Examine comprehensive strategies to prevent MSDs in the workplace, effectively manage reported MSDs to minimize impact to your organization, and tools to prevent MSDs from re-occurring
  • Examine ergonomic program maturity across regions, from regulation-driven assessments in the UK and Europe to awareness-building campaigns in APAC and voluntary participation in the US
  • Gain a practical roadmap for designing flexible, inclusive ergonomics programmes that respect local norms yet uphold a consistent global safety standard

2:30 pm Panel Discussion: Embedding Mental Health into Biopharma EHS Culture

, Independent EHS Professional
Director, Safety, Health & Environmental, AstraZeneca
Executive Director - Global Occupational Health, Environment Health & Safety, Amgen
  • How can EHS teams meaningfully integrate mental health and stress management into existing safety programmes without diluting their core mission?
  • What practical interventions, from workload design to leadership training, have proven most effective in preventing burnout and promoting psychological safety on site?
  • How can data on fatigue, ergonomics, and incident trends be used to make a compelling business case for mental health investment in biopharma?

3:30 pm Chair’s Closing Remarks